May 1, 2017 09:50 AM EDTUpdated 10:12 AM

Robert Plenge tapped to run immunology R&D at Celgene; Tesaro files LAG-3 IND

Shehla Shakoor

Managing Director

→ Robert Plenge is taking the plunge at Celgene. The ex-Merck investigator is moving out of Big Pharma to take charge of immunology research for …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Robert Plenge tapped to run immunology R&D at Celgene; Tesaro files LAG-3 IND

Shehla Shakoor

Managing Director

Sign up to read this article for free.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA

Exclusive: Influential Democrat will oppose Biosecure Act ahead of House vote

Astellas CEO talks future beyond Xtandi as Japanese drugmaker puts roots in Boston

BridgeBio sticks to script for ATTR-CM as Alnylam cleans up ‘typo’ snafu

Roche's Spark loses CEO to RNA upstart; Ex-Elevation Oncology chief takes over at Affimed

Lilly inks obesity deal with seed-stage RNA startup as its genetic medicines effort enters the spotlight

How to secure full enrollment and a 30x ROI: A conversation with the CEO of the boutique enrollment agency doing just ...

Robert Plenge tapped to run im­munol­o­gy R&D at Cel­gene; Tesaro files LAG-3 IND

Managing Director

Sign up to read this article for free.

Viridian Therapeutics

Waltham, MA, USA

Robert Plenge tapped to run immunology R&D at Celgene; Tesaro files LAG-3 IND